PFO
GHSI

Pathstone Family Office’s Guardion Health Sciences, Inc. Common Stock GHSI Stock Holding History

Pathstone Family Office’s Portfolio GHSI Stock Details GHSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2
Closed – – 1003
2020
Q1 		$0 Buy
+2
New +$211 ﹤0.01% 838

Other funds holding GHSI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pathstone Family Office's GHSI Position: Q2 2020 in Review

Pathstone Family Office sold out of Guardion Health Sciences, Inc. Common Stock (GHSI) in Q2 2020, closing a stake of 2 shares.

Pathstone Family Office first reported a position in GHSI in Q1 2020 and held it in 1 quarter. The position peaked at $0 in Q1 2020. 18 funds tracked by Wall St. Rank hold GHSI as of Q2 2020.

  • Pathstone Family Office reported no remaining Guardion Health Sciences, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Pathstone Family Office sold 2 Guardion Health Sciences, Inc. Common Stock shares in Q2 2020.
  • Pathstone Family Office first reported a position in Guardion Health Sciences, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Pathstone Family Office's Guardion Health Sciences, Inc. Common Stock position peaked at $0 in Q1 2020.
  • 18 funds tracked by Wall St. Rank held Guardion Health Sciences, Inc. Common Stock as of Q2 2020.

Based on Pathstone Family Office's 13F filing for Q2 2020, filed 14 Aug 2020.